Current through all regulations passed and filed through September 16, 2024
(A) Raw milk or milk products intended for
use in the manufacturing of frozen desserts shall not be accepted
by the manufacturer of frozen
desserts
unless the milk and milk products meet
the following standards at the time of delivery and are
maintained by the manufacturer of frozen desserts through pasteurization:
(1) Temperature at
forty-five degrees Fahrenheit (seven
degrees Celsius) or less;
(2)
Bacterial limits not to exceed three-hundred
thousand parts per milliliter
and tested in
conjunction with the drug residue inhibitory substance test; and
(3)
No positive results on
a drug residue inhibitory
substance test using
methods that are analyzed at an officially
designated laboratory using examinations in substantial compliance with
the "Appendix N of the "PMO".
(B) Bulk loads of raw milk and milk products
shall be pasteurized in accordance with rule
901:11-3-05 of the
Administrative Code at the receiving plant prior to use in the manufacturing of
finished products.
(C) Bulk loads
of pasteurized milk or milk products shall be re-pasteurized in accordance with
rule 901:11-3-05 of the
Administrative Code at the receiving plant prior to use in the manufacturing of
finished products.
(D) Frozen
desserts made from pasteurized milk or milk products shall meet the following
standards after pasteurization:
(1) Temperature at
forty-five degrees
Fahrenheit (seven degrees Celsius) or less;
(2) Bacterial limits
not
to exceed thirty thousand parts per
milliliter;
and
(3) Coliform
not
to exceed ten parts per milliliter.
(E)
During at least
four separate months within any consecutive six-month period, samples of each
type of product produced will be collected for examination to determine the
bacterial and/or coliform counts of the samples, in addition to determining the
presence of drug residues.
(1)
Whenever two of the last four bacteria or coliform
counts exceed the standards established in paragraphs (A)(2), (D)(2) and (D)(3)
of this rule, the director will send a written warning notice to the processor.
The notice will be in effect so long as two of the last four consecutive
samples exceed the bacterial or coliform standard.
(2)
An additional
sample will be taken no sooner than three days and no later than twenty-one
days after sending of the warning notice required in paragraph (E)(1) of this
rule. If this sample also exceeds the bacteria or coliform standards
established in paragraphs (A)(2), (D)(2) and (D)(3) of this rule, the processor
license shall be suspended until satisfactory compliance is obtained. The
license may be reinstated by the director when an additional sample of the
product(s) in violation is tested and found satisfactory.
(3)
Whenever a drug
residue test is positive following the standards established in (A)(3) of this
rule, the procedures of the "Appendix N of the PMO" will be followed to
identify the source of the positive result.
